Waldencast plc (WALD)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Waldencast plc (“Waldencast” or “the Company”) (NASDAQ: WALD). Investors who purchased Waldencast securities are encouraged to obtain additional information and assist the investigation.
The investigation concerns whether Waldencast has violated federal securities laws.
Waldencast Investigation Details
On November 24, 2025, Waldencast issued a press release reporting its financial results for the second quarter of 2025. Therein, the Company updated its financial outlook for the full year of 2025, expecting net revenue to be broadly in line with 2024 and adjusted EBITDA margin in the high single digits. Previously, Waldencast had guided to mid-teens net revenue growth and an adjusted EBITDA margin in the mid-to-high teens. The Company also reported a net loss of $185.2 million for the first half of 2025, primarily driven by impairment charges of $132.1 million and $20 million on its Obagi Medical and Milk Makeup brands, respectively. Following this news, Waldencast’s Class A ordinary share price fell $0.20 per share, or 6.49%, to close at $2.88 per share on November 24, 2025.
What’s Next for Waldencast Investors?
If you are aware of any facts relating to this investigation or purchased Waldencast securities, you can assist this investigation by visiting the firm’s site: bgandg.com/WALD. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 917-590-0911
No Cost to Waldencast Investors
We, Bronstein, Gewirtz & Grossman, LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman, LLC For Waldencast Securities Investigation?
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
“Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace,” said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.
Follow us for updates on LinkedIn, X, Facebook, or Instagram.
Contact Info
Peretz Bronstein, Esq. or Nathan Miller
Bronstein, Gewirtz & Grossman, LLC
917-590-0911 | [email protected]
Attorney advertising.
Prior results do not guarantee similar outcomes.